S. ASHWORTH: Open Payments
NPI 1457550543 · POWDER SPRINGS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$814 in 42 payments from 16 companies in 2025. Trend: 2023 $748 · 2024 $1,067 · 2025 $814
Food & beverage: $814
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $209 |
| ABBVIE INC. | 6 | $112 |
| Abbott Laboratories | 5 | $85 |
| PFIZER INC. | 4 | $82 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| SANOFI-AVENTIS U.S. LLC | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| SHIELD THERAPEUTICS INC | 1 | $24 |
Products named: FREESTYLE LIBRE 3, UBRELVY, Rybelsus, LEQVIO, CAPLYTA, TZIELD, ELIQUIS, Wegovy.
Industry payments across GA — which companies pay providers there.
